Hot Investor Mandate: Western Europe Investment Firm Invest Up to $10M in Life Science Technologies, Including Orphan Indications and Strong Interests in Vaccines

23 May

A venture capital firm that currently manages 2 funds makes equity and mezzanine investments into venture stage companies in the life science space ranging from $1 -10 million over the lifetime of the investment. The firm has a geographical focus on companies in Western Europe plans to make 2-3 investments over the next 6-9 months.

The firm is looking for companies in the Therapeutics, Diagnostics and Medical Technology spaces. While the firm considers all subsectors and indications, including orphan indications, they are especially interested in the vaccine field. The firm generally looks for companies that have proof of concept from animal studies generally investing in Series A rounds. The firm is very open to repurposed and reformulations and they generally only consider investment into biosimilars when a strong case for a high value inflection point can be made.

The firm looks for experienced management teams and generally looks to take a board seat. The firm often leads or co-leads investment rounds always looking to take an active role in the development of its portfolio companies.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: